These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 38172305)
1. Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice. Shao JJ; Li WF; Sun JF; Zhuang ZS; Min JL; Long XH; Wu GJ; Xu HW; Liang G Acta Pharmacol Sin; 2024 Apr; 45(4):803-814. PubMed ID: 38172305 [TBL] [Abstract][Full Text] [Related]
2. Discovery of alantolactone as a naturally occurring NLRP3 inhibitor to alleviate NLRP3-driven inflammatory diseases in mice. Li W; Xu H; Shao J; Chen J; Lin Y; Zheng Z; Wang Y; Luo W; Liang G Br J Pharmacol; 2023 Jun; 180(12):1634-1647. PubMed ID: 36668704 [TBL] [Abstract][Full Text] [Related]
3. Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling. Lin Y; Luo T; Weng A; Huang X; Yao Y; Fu Z; Li Y; Liu A; Li X; Chen D; Pan H Front Immunol; 2020; 11():580593. PubMed ID: 33365024 [TBL] [Abstract][Full Text] [Related]
4. Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3. Yan CY; Ouyang SH; Wang X; Wu YP; Sun WY; Duan WJ; Liang L; Luo X; Kurihara H; Li YF; He RR Phytomedicine; 2021 Jan; 80():153398. PubMed ID: 33130474 [TBL] [Abstract][Full Text] [Related]
5. Tabersonine, a natural NLRP3 inhibitor, suppresses inflammasome activation in macrophages and attenuate NLRP3-driven diseases in mice. Xu HW; Li WF; Hong SS; Shao JJ; Chen JH; Chattipakorn N; Wu D; Luo W; Liang G Acta Pharmacol Sin; 2023 Jun; 44(6):1252-1261. PubMed ID: 36627344 [TBL] [Abstract][Full Text] [Related]
6. Dehydrocostus lactone inhibits NLRP3 inflammasome activation by blocking ASC oligomerization and prevents LPS-mediated inflammation in vivo. Chen Y; Li R; Wang Z; Hou X; Wang C; Ai Y; Shi W; Zhan X; Wang JB; Xiao X; Bai Z; Sun H; Xu G Cell Immunol; 2020 Mar; 349():104046. PubMed ID: 32057354 [TBL] [Abstract][Full Text] [Related]
7. Baeckein E suppressed NLRP3 inflammasome activation through inhibiting both the priming and assembly procedure: Implications for gout therapy. Lin X; Wang H; An X; Zhang J; Kuang J; Hou J; Yan M Phytomedicine; 2021 Apr; 84():153521. PubMed ID: 33667838 [TBL] [Abstract][Full Text] [Related]
8. Geraniin restricts inflammasome activation and macrophage pyroptosis by preventing the interaction between ASC and NLRP3 to exert anti-inflammatory effects. Zhou X; Qin M; He L; Zhang Y; Liu A; Chen D; Pan H Int Immunopharmacol; 2024 Mar; 129():111656. PubMed ID: 38340422 [TBL] [Abstract][Full Text] [Related]
9. Ergolide covalently binds NLRP3 and inhibits NLRP3 inflammasome-mediated pyroptosis. Ren M; Chen J; Xu H; Li W; Wang T; Chi Z; Lin Y; Zhang A; Chen G; Wang X; Sun X; Liang G; Wang J; Luo W Int Immunopharmacol; 2023 Jul; 120():110292. PubMed ID: 37182452 [TBL] [Abstract][Full Text] [Related]
10. Scoparone suppresses mitophagy-mediated NLRP3 inflammasome activation in inflammatory diseases. Feng WD; Wang Y; Luo T; Jia X; Cheng CQ; Wang HJ; Zhang MQ; Li QQ; Wang XJ; Li YY; Wang JY; Huang GR; Wang T; Xu AL Acta Pharmacol Sin; 2023 Jun; 44(6):1238-1251. PubMed ID: 36522512 [TBL] [Abstract][Full Text] [Related]
11. Corilagin Restrains NLRP3 Inflammasome Activation and Pyroptosis through the ROS/TXNIP/NLRP3 Pathway to Prevent Inflammation. Luo T; Zhou X; Qin M; Lin Y; Lin J; Chen G; Liu A; Ouyang D; Chen D; Pan H Oxid Med Cell Longev; 2022; 2022():1652244. PubMed ID: 36299604 [TBL] [Abstract][Full Text] [Related]
12. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158 [TBL] [Abstract][Full Text] [Related]
13. Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases. Fang ZE; Wang Y; Bian S; Qin S; Zhao H; Wen J; Liu T; Ren L; Li Q; Shi W; Zhao J; Yang H; Peng R; Wang Q; Bai Z; Xu G Phytomedicine; 2024 Jan; 122():155159. PubMed ID: 37931457 [TBL] [Abstract][Full Text] [Related]
14. Brevilin A inhibits NLRP3 inflammasome activation in vivo and in vitro by acting on the upstream of NLRP3-induced ASC oligomerization. Qin Q; Xu G; Zhan X; Wang Z; Wang Y; Liu H; Hou X; Shi W; Ma J; Bai Z; Xiao X Mol Immunol; 2021 Jul; 135():116-126. PubMed ID: 33892379 [TBL] [Abstract][Full Text] [Related]
15. Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway. Li X; Qiu H; Gan J; Liu Z; Yang S; Yuan R; Gao H J Ethnopharmacol; 2023 Oct; 314():116478. PubMed ID: 37121449 [TBL] [Abstract][Full Text] [Related]
16. Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis. Yang G; Lee HE; Moon SJ; Ko KM; Koh JH; Seok JK; Min JK; Heo TH; Kang HC; Cho YY; Lee HS; Fitzgerald KA; Lee JY Arthritis Rheumatol; 2020 Jul; 72(7):1192-1202. PubMed ID: 32134203 [TBL] [Abstract][Full Text] [Related]
17. NLRP3 inflammasome inhibitor cucurbitacin B suppresses gout arthritis in mice. Xue Y; Li R; Fang P; Ye ZQ; Zhao Y; Zhou Y; Zhang KQ; Li L J Mol Endocrinol; 2021 Jun; 67(2):27-40. PubMed ID: 34047713 [TBL] [Abstract][Full Text] [Related]
18. A small molecule inhibitor of caspase-1 inhibits NLRP3 inflammasome activation and pyroptosis to alleviate gouty inflammation. Cao DY; Zhang ZH; Li RZ; Shi XK; Xi RY; Zhang GL; Li F; Wang F Immunol Lett; 2022 Apr; 244():28-39. PubMed ID: 35288207 [TBL] [Abstract][Full Text] [Related]
19. Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation. Zhao Q; Bi Y; Guo J; Liu YX; Zhong J; Pan LR; Tan Y; Yu XJ Acta Pharmacol Sin; 2021 Jun; 42(6):975-986. PubMed ID: 32989235 [TBL] [Abstract][Full Text] [Related]
20. Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1β and Cathepsin B in macrophages. Qiao CY; Li Y; Shang Y; Jiang M; Liu J; Zhan ZY; Ye H; Lin YC; Jiao JY; Sun RH; Zhang ZH; Piao MH; Wu YL; Nan JX; Lian LH Inflammopharmacology; 2020 Dec; 28(6):1481-1493. PubMed ID: 33006110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]